The ERA-Net "ERAIB - European Research Area Industrial Biotechnology" has published a call with Deadline 1 February 2016.
Deadline: 1st February 2016
Publication date: 3rd November 2015
Short Call Abstract:
The strategic objective of ERA-IB-2 calls is to foster the competitiveness of Europe´s industrial biotechnology research by supporting academic and industrial research and their strategic partnerships. The ERA-IB-2 focus is to support innovation and pre-competitive research by funding projects with challenging application aspects and a substantial industrial impact. Note that the projects which do not fit the scope of the call will be rejected before the evaluation phase.
Industrial Biotechnology (IB) is essential for the construction of the Knowledge-Based Bio- Economy (KBBE) and to transform life sciences knowledge into new, sustainable, eco-efficient and competitive products and technologies.
One of the three evaluation criteria is the Economic and social perspective (weighting factor 3x)
1. potential of the expected results for industrial application, including knowledge about the current patent situation,
2. environmental and ethical issues,
3. integration into the whole value-added chain, e.g. industrial exploitation
4. expected economic potential (exploitation of results) and social perspective of Outputs
Specific participation requirements:
The main purpose of the call is to generate joint European research and development activities. Joint projects must have a minimum of three and maximum of eight participants from a minimum of three different ERA-IB-2, ERASynBio and/or ERA-MBT partner countries.
The participation of an industrial partner in the consortium is recommended but not mandatory.
Countries Flanders/Belgium, Finland, Germany, Germany/Saxony, Latvia, Norway, Poland, Romania, Russia, Spain, Switzerland, Turkey